NIAID Banner Logo Image

HIV Citations List: October 2023

Literature Citations

1. 4-Phenylcoumarin Derivatives as New HIV-1 NNRTIs: Design, Synthesis, Biological Activities, and Computational Studies. Batran, R.Z., A. Sabt, M.A. Khedr, A.K. Allayeh, C. Pannecouque, and A.F. Kassem. Bioorganic Chemistry, 2023. 141: 106918. PMID[37866206].
[PubMed]. HIV_10_2023.

2. Synthesis, Spectroscopic Analysis, Biological Evaluation, and in Silico Studies of Novel Benzenesulfonate-derived Schiff-Mannich Bases. Harmankaya, A., N. Kilinç, M. Beytur, Y. Yilmaz, S. Manap, and H. Yüksek. Journal of the Chemical Society of Pakistan, 2023. 45(4): p. 323-335. ISI[001068213100008].
[WOS]. HIV_10_2023.

3. (±) Camptothecol, a Pair of Ditetrahydrofuran Lignans Enantiomers from the Fruit of Camptotheca acuminate and Structure Revision of Biphenylneolignan. Liu, X., S.H. Dong, J.L. Hao, B. Lin, M. Bai, X.X. Huang, and S.J. Song. Journal of Molecular Structure, 2024. 1295: 136600. ISI[001075221600001].
[WOS]. HIV_10_2023.

4. Synthesis and Antiviral and Antitumor Activities of Novel 18β-Glycyrrhetinic acid Derivatives. Pan, B.W., L.L. Zheng, Y. Shi, Z.C. Dong, T.T. Feng, J. Yang, Y. Wei, and Y. Zhou. International Journal of Molecular Sciences, 2023. 24(19): 15012. PMID[37834459]. PMCID[PMC10573640].
[PubMed]. HIV_10_2023.

5. One Pot Synthesis, Crystal Structure, Hirshfeld Studies, Docking Simulation and Antimicrobial Efficacy Assay of New Fused/Substituted Pyrazolinyl-thiazolidinyl-indolone triheterocyclic Hybrid Scaffolds. Salian, V.V., B. Narayana, B.K. Sarojini, M.S. Kumar, and K.S. Chandra. Polycyclic Aromatic Compounds, 2023. ISI[001073066400001].
[WOS]. HIV_10_2023.

6. In Vitro and in Silico Antiviral Activity of Di-Halogenated Compounds Derived from L-Tyrosine against Human Immunodeficiency Virus 1 (HIV-1). Serna-Arbeláez, M.S., V. García-Cárcamo, D.S. Rincón-Tabares, D. Guerra, V. Loaiza-Cano, M. Martinez-Gutierrez, J.A. Pereañez, M. Pastrana-Restrepo, E. Galeano, and W. Zapata. Current Issues in Molecular Biology, 2023. 45(10): p. 8173-8200. PMID[37886959]. PMCID[PMC10605077].
[PubMed]. HIV_10_2023.

7. Novel β-L-1,3-Thiazolidine pyrimidine nucleoside Analogues: Design, Synthesis, Molecular Docking, and anti-HIV Activity. Sriharsha, S.N., N.H. Jainab, M.S. Biradar, S. Thapa, E.S. Venkatesh, D.P. Bidye, G. Pujar, and S. Dixit. Journal of Molecular Structure, 2023. 1294: 136304. ISI[001059616000001].
[WOS]. HIV_10_2023.

8. Exploring Antiviral Potency of N-1 Substituted Pyrimidines against HIV-1 and Other DNA/RNA Viruses: Design, Synthesis, Characterization, ADMET Analysis, Docking, Molecular Dynamics and Biological Activity. Srivastava, R., S.K. Gupta, F. Naaz, P.S. Sen Gupta, M. Yadav, V.K. Singh, S.K. Panda, S. Biswal, M.K. Rana, S.K. Gupta, D. Schols, and R.K. Singh. Computational Biology and Chemistry, 2023. 106: 107910. PMID[37422940].
[PubMed]. HIV_10_2023.

9. Design, Synthesis and Biological Evaluation of 2,4,6-Trisubstituted triazine Derivatives as New Nonpeptide Small-molecule SIRT5 Inhibitors. Wang, L.J., L. Hu, J.L. Deng, S.Y. Hou, L.H. Mou, P.C. Lei, X. Chen, J.Y. Liu, Y.Y. Jiang, R. Xiong, X.Q. Tian, W.F. Zhang, R. Li, W.Y. Yang, and L.L. Yang. Bioorganic & Medicinal Chemistry, 2023. 93: 117455. PMID[37643500].
[PubMed]. HIV_10_2023.

10. Improving the anti-HIV-1 Activity and Solubility of Poorly Water-soluble DAPYs by Heteroaromatic Replacement Strategy: From Naphthalene-DAPYs to Quinoline-DAPYs. Zhou, R.L., C. Yu, C. Pannecouque, E. De Clercq, S. Wang, and F.E. Chen. Bioorganic Chemistry, 2023. 140: 106821. PMID[37659148].
[PubMed]. HIV_10_2023.

Patent Citations

11. Bridged Tricyclic Carbamoylpyridone Compounds and Uses Thereof. Chu, H., A.Z. Gonzalez Buenrostro, X. Han, A.E. Hurtley, L. Jiang, J. Li, G.M. Schwarzwalder, D.M. Shivakumar, M.J. Von Bargen, Q. Wu, and H. Yang. Patent. 2023. WO2023-US65401 2023196875: 414 pp.
[Patent]. HIV_10_2023.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: January 2024